yes agree May have been different outcomes if only SPL had efficacy clinical trial and submitted product in category they were told by TGA.
time is money in biotech and especially pandemic time. If only you SPL not argue with the regulator so many times and learn that It’s not quick or smart.
- Forums
- ASX - By Stock
- Anthony Albanese/Mark McGowan and VIRALEZE™
yes agree May have been different outcomes if only SPL had...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.003(3.30%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.2¢ | 9.4¢ | 9.2¢ | $45.38K | 485.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13985 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 10461 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13985 | 0.094 |
2 | 126688 | 0.092 |
2 | 123413 | 0.091 |
3 | 102750 | 0.090 |
2 | 97420 | 0.089 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 10461 | 4 |
0.099 | 8279 | 3 |
0.100 | 115181 | 5 |
0.105 | 66531 | 3 |
0.110 | 16500 | 2 |
Last trade - 12.24pm 26/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online